| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An approach for improvement of the accuracy of cancer gene panel testing
|
Imoto, Kiyomi
|
|
|
29 |
5 |
p. 571-581
|
artikel
|
| 2 |
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab
|
Hashimoto, Masaki
|
|
|
29 |
5 |
p. 612-619
|
artikel
|
| 3 |
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
|
Hashimoto, Tadayoshi
|
|
|
29 |
5 |
p. 495-511
|
artikel
|
| 4 |
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
|
Kikuchi, Yoshinori
|
|
|
29 |
5 |
p. 512-534
|
artikel
|
| 5 |
Current status of head and neck sarcomas in Japan in 2016–2019: an analysis using the national cancer registry
|
Rikitake, Ryoko
|
|
|
29 |
5 |
p. 564-570
|
artikel
|
| 6 |
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022
|
Kimura, Shoji
|
|
|
29 |
5 |
p. 559-563
|
artikel
|
| 7 |
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022
|
Uchino, Keita
|
|
|
29 |
5 |
p. 545-550
|
artikel
|
| 8 |
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology
|
Maeda, Tomoya
|
|
|
29 |
5 |
p. 535-544
|
artikel
|
| 9 |
Lymphatic drainage patterns of malignant skin tumors in the head and neck region: a single-center retrospective study
|
Nishio, Takuya
|
|
|
29 |
5 |
p. 582-591
|
artikel
|
| 10 |
Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial
|
Matsui, Motohiro
|
|
|
29 |
5 |
p. 629-637
|
artikel
|
| 11 |
MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial
|
Kang, Han Byul
|
|
|
29 |
5 |
p. 620-628
|
artikel
|
| 12 |
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022
|
Ozaki, Yukinori
|
|
|
29 |
5 |
p. 551-558
|
artikel
|
| 13 |
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
|
Taoka, Rikiya
|
|
|
29 |
5 |
p. 602-611
|
artikel
|
| 14 |
PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan
|
Matsumura, Noriomi
|
|
|
29 |
5 |
p. 493-494
|
artikel
|
| 15 |
Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy
|
Gao, Zhimin
|
|
|
29 |
5 |
p. 592-601
|
artikel
|
Tijdschrift beschrijving